KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for National Health Investors (NHI) over the last 16 years, with Q3 2025 value amounting to $20.2 million.

  • National Health Investors' Depreciation & Amortization (CF) rose 1377.76% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.0 million, marking a year-over-year increase of 1158.8%. This contributed to the annual value of $71.4 million for FY2024, which is 210.08% up from last year.
  • National Health Investors' Depreciation & Amortization (CF) amounted to $20.2 million in Q3 2025, which was up 1377.76% from $19.9 million recorded in Q2 2025.
  • National Health Investors' 5-year Depreciation & Amortization (CF) high stood at $20.8 million for Q1 2021, and its period low was $17.1 million during Q4 2023.
  • In the last 5 years, National Health Investors' Depreciation & Amortization (CF) had a median value of $17.8 million in 2022 and averaged $18.5 million.
  • As far as peak fluctuations go, National Health Investors' Depreciation & Amortization (CF) tumbled by 1397.04% in 2022, and later soared by 1388.22% in 2025.
  • Quarter analysis of 5 years shows National Health Investors' Depreciation & Amortization (CF) stood at $19.3 million in 2021, then dropped by 10.34% to $17.3 million in 2022, then fell by 1.11% to $17.1 million in 2023, then increased by 9.17% to $18.7 million in 2024, then rose by 8.22% to $20.2 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $20.2 million for Q3 2025, versus $19.9 million for Q2 2025 and $19.2 million for Q1 2025.